Team

Rasmus Møller

PhD Candidate
EDUCATION AND TRAINING

BIOGRAPHY

Rasmus Møller is a fourth year Ph.D. candidate in the tenOever lab.  Rasmus’ research focuses on the repurposing of bacterial and archaeal antiviral defense system, CRISPR, for biotechnological applications and therapeutics for COVID-19.

Rasmus completed his bachelor degree in Molecular Biomedicine at University of Copenhagen in Denmark where he also did his thesis work on archaeal virology in the Danish Archaea Centre. His undergraduate studies included a stay at University of Washington in Seattle.  He aslo completed a Master’s degree in the tenOever lab with his work on how human cytomegalovirus hijacks the host transcriptional response upon infection. 


PUBLICATIONS

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

Longlong Si # 1, Haiqing Bai # 1, Melissa Rodas 1, Wuji Cao 1, Crystal Yuri Oh 1, Amanda Jiang 1 2, Rasmus Moller 3, Daisy Hoagland 3, Kohei Oishi 3, Shu Horiuchi 3, Skyler Uhl 3, Daniel Blanco-Melo 3, Randy A Albrecht 3, Wen-Chun Liu 3, Tristan Jordan 3, Benjamin E Nilsson-Payant 3, Ilona Golynker 3, Justin Frere 3, James Logue 4, Robert Haupt 4, Marisa McGrath 4, Stuart Weston 4, Tian Zhang 5, Roberto Plebani 1 6, Mercy Soong 1, Atiq Nurani 1, Seong Min Kim 1, Danni Y Zhu 1, Kambez H Benam 1 7 8, Girija Goyal 1, Sarah E Gilpin 1, Rachelle Prantil-Baun 1, Steven P Gygi 5, Rani K Powers 1, Kenneth E Carlso n 1, Matthew Frieman 4, Benjamin R tenOever 3, Donald E Ingber 9 10.

Nature Biomedical Engineering 03/05/2021

PMID: 33941899

Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection

Dobrindt K, Hoagland DA, Seah C, Kassim B, O'Shea CP, Murphy A, Iskhakova M, Fernando MB, Powell SK, Deans PJM, Javidfar B, Peter C, Møller R, Uhl SA, Garcia MF, Kimura M, Iwasawa K, Crary JF, Kotton DN, Takebe T, Huckins LM, tenOever BR, Akbarian S, Brennand KJ

Stem Cell Reports 09/03/2021

PMID: 33636110

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Hoagland DA, Møller R, Uhl SA, Oishi K, Frere J, Golynker I, Horiuchi S, Panis M, Blanco-Melo D, Sachs D, Arkun K, Lim JK, tenOever BR.

Immunity 09/03/2021

PMID: 33577760

SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2

Chen S, Yang L, Nilsson-Payant B, Han Y, Jaffré F, Zhu J, Wang P, Zhang T, Redmond D, Houghton S, Møller R, Hoagland D, Horiuchi S, Acklin J, Lim J, Bram Y, Richardson C, Chandar V, Borczuk A, Huang Y, Xiang J, Ho D, Schwartz R, tenOever B, Evans T.

Res Sq 17/11/2020

PMID: 33236003